STOCK TITAN
  1. Home
  2. News
  3. LFMDP

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock - LFMDP STOCK NEWS

Welcome to our dedicated page for LifeMD 8.875% Series A Cumulative Perpetual Preferred Stock news (Ticker: LFMDP), a resource for investors and traders seeking the latest updates and insights on LifeMD 8.875% Series A Cumulative Perpetual Preferred Stock stock.

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (symbol: LFMDP) is backed by a company that offers a comprehensive telemedicine solution connecting physicians, medical providers, pharmacists, and patients worldwide. Their platform is HIPAA-compliant and encrypted, allowing for secure interactions and management of medical conditions. In addition to telehealth services, they also provide mobile diagnostic telehealth equipment and sell nutritional supplements and over-the-counter products. With a focus on virtual primary care, LifeMD is committed to providing accessible, high-quality healthcare services.

News

LifeMD to Report Third Quarter 2023 Financial Results on November 8

Rhea-AI Summary
LifeMD, Inc. will report financial results for Q3 2023 on November 8th and host a conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.22%
Tags
conferences earnings
-
News

Particle Health and LifeMD Demonstrate the Potential of Using Comprehensive Electronic Health Record Data to Triage Patients for GLP-1 Weight Management Therapy

Rhea-AI Summary
Joint research study by Particle Health and LifeMD demonstrates that Particle's platform can help healthcare providers contextualize patient data and identify eligibility for GLP-1 treatment, potentially saving physicians time and improving patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.79%
Tags
none
-
News

LifeMD to Participate in Two Investor Conferences in October

Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) to participate in investor conferences in October.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences
News

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Rhea-AI Summary
LifeMD, Inc. authorizes cash dividend of $0.5546875 per share for its 8.875% Series A Cumulative Perpetual Preferred Stock, payable on October 16, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.42%
Tags
dividends
-
News

LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy

Rhea-AI Summary
LifeMD partners with ASCEND Therapeutics to provide integrated telehealth services for EstroGel® 0.06%
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
none
-
News

LifeMD to Participate in Two Investor Conferences in September

Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) to participate in investor conferences in September.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.16%
Tags
conferences
News

LifeMD Reports Second Quarter 2023 Results; Achieves Positive Free Cash Flow and Raises 2023 Revenue Guidance

Rhea-AI Summary
LifeMD reports record quarterly revenue of $35.9 million, up 18% YoY. Telehealth net revenues increased 11% from Q1 2023. Positive free cash flow achieved. Adjusted EBITDA increased to $1.7 million from a loss of $6.9 million in the year-ago period. Weight Management program expected to be accretive in 2024. Raised 2023 revenue guidance to $146 million to $152 million. Conference call at 4:30 p.m. Eastern time today.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.67%
Tags
earnings
-
News

LifeMD to Present at Sidoti’s Micro-Cap Virtual Conference

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
conferences
-
News

LifeMD to Report Second Quarter 2023 Financial Results on August 9

Rhea-AI Summary
LifeMD, Inc. (LFMD) to Report Q2 2023 Financial Results on August 9, 2023. The leading provider of virtual primary care services will host a conference call at 4:30 p.m. Eastern time. Investors can access the live & archived webcast using the provided link.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.99%
Tags
conferences earnings
News

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.07%
Tags
dividends

FAQ

What is the current stock price of LifeMD 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP)?

The current stock price of LifeMD 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) is $21.866 as of November 4, 2024.

What does LifeMD, Inc. offer?

LifeMD offers a comprehensive telemedicine solution connecting physicians, medical providers, pharmacists, and patients worldwide.

Is LifeMD's platform secure?

Yes, LifeMD's platform is HIPAA-compliant and all interactions are encrypted for security.

What products does LifeMD sell?

In addition to telehealth services, LifeMD sells nutritional supplements and over-the-counter products.

What is the focus of LifeMD's services?

LifeMD is focused on providing virtual primary care to make high-quality healthcare accessible for all.

How does LifeMD contribute to the healthcare industry?

LifeMD's telemedicine platform and services aim to improve patient outcomes and provide more convenient access to healthcare.

Stock LFMDP logo
LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock

Nasdaq:LFMDP

LFMDP Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

LFMDP Stock Data

1.40M
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
NEW YORK